GLAXO - Swing Trade Analysis with AI Signals
Back to Listπ Swing Trade Rating: 3.6
| Stock Code | GLAXO | Market Cap | 38,407 Cr. | Current Price | 2,266 βΉ | High / Low | 3,500 βΉ |
| Stock P/E | 42.3 | Book Value | 132 βΉ | Dividend Yield | 2.52 % | ROCE | 61.3 % |
| ROE | 43.3 % | Face Value | 10.0 βΉ | DMA 50 | 2,300 βΉ | DMA 200 | 2,477 βΉ |
| Chg in FII Hold | -0.01 % | Chg in DII Hold | -0.02 % | PAT Qtr | 275 Cr. | PAT Prev Qtr | 277 Cr. |
| RSI | 53.0 | MACD | -44.1 | Volume | 2,83,473 | Avg Vol 1Wk | 3,26,476 |
| Low price | 2,088 βΉ | High price | 3,500 βΉ | PEG Ratio | 2.70 | Debt to equity | 0.01 |
| 52w Index | 12.6 % | Qtr Profit Var | 5.69 % | EPS | 59.7 βΉ | Industry PE | 32.1 |
GLAXO shows strong fundamentals with high ROCE (61.3%) and ROE (43.3%), a low debt-to-equity ratio (0.01), and a healthy dividend yield of 2.52%. However, technical indicators are weak: the current price (βΉ2,266) is below both the 50 DMA (βΉ2,300) and 200 DMA (βΉ2,477), MACD is negative (-44.1), and volume is lower than the weekly average. RSI at 53.0 suggests neutral momentum. Valuation is stretched with a P/E of 42.3 compared to the industry average of 32.1 and a high PEG ratio of 2.70. Overall, GLAXO is fundamentally strong but technically weak, making it a cautious swing trade candidate.
π― Optimal Entry Price
Entry around βΉ2,200β2,240 is favorable, aligning with support near recent lows.
π Exit Strategy
If already holding, consider exiting near βΉ2,400β2,450 (resistance zone close to 200 DMA). A stop-loss below βΉ2,150 is advisable to manage risk.
β Positive
- π Strong ROCE (61.3%) and ROE (43.3%) highlight efficiency.
- π Dividend yield of 2.52% provides steady income.
- π Debt-to-equity ratio of 0.01 ensures financial stability.
- π EPS of βΉ59.7 supports earnings consistency.
β οΈ Limitation
- π Current price below both DMA 50 and DMA 200 indicates bearish trend.
- π Negative MACD (-44.1) signals weak momentum.
- π High P/E (42.3) compared to industry average (32.1) suggests overvaluation.
- π PEG ratio of 2.70 indicates expensive growth.
- π FII (-0.01%) and DII (-0.02%) holdings declined, showing reduced institutional confidence.
π° Company Negative News
- π No major negative news reported, but valuation concerns persist.
π Company Positive News
- π Stable quarterly profits (βΉ275 Cr. vs βΉ277 Cr.).
- π Strong efficiency metrics and consistent dividend payout.
π Industry
- π Industry P/E of 32.1 is lower than GLAXOβs 42.3, suggesting relative overvaluation.
- π Pharmaceutical sector remains resilient with consistent demand.
π Conclusion
GLAXO is fundamentally strong but technically weak for swing trading. Entry near βΉ2,200β2,240 offers limited upside, with profit booking advisable near βΉ2,400β2,450. A strict stop-loss below βΉ2,150 is essential to manage risk effectively.
Would you like me to also compute a risk-reward ratio for this setup, or provide a deeper technical chart analysis to refine the swing trade outlook?